Notícias e Atividades da Protagen

A Protagen pertence à Oncimmune. Oncimmune tem presença direta em 2 países.

Veja o organograma con seus 7 executivos principais

Biografias mais buscadas da Protagen

• Roland Moussa, President, EU
• Tina Gerhards, Vice President, Quality Management
• André Abts, Vice President, Project Management Chemistry, Manufac...

Recentes movimentos de executivos em Oncimmune

• Martin Hudson, Chief Financial Officer, deixou a Companhia  (Notícia publicada em 10 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Protagen.

Oncimmune possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Protagen

• Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene
• Protagen Protein Services (PPS) expands analytical Service Spectrum in Biotherapeutical Development Support
• Mass spectrometry in cell and gene therapy development projects – a versatile tool for CGT in-depth studies
• Protagen Protein Service Merge with Panatecs
• Our latest mAbs publication: Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination
• Protagen AG sells Service Business
• Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms | Protagen
• New brochure "CELL AND GENE THERAPY - ANALYTICAL SERVICES FOR VIRAL DELIVERY SYSTEMS" is now available | Protagen
• ADVANCED MS APPROACHES FOR THE CHARACTERIZATION OF ADC HETEROGENEITY AND STABILITY | Protagen
• Our new Application Note: Advanced MS Approaches for the Characterization of ADC Heterogenity and Stability | Protagen
• View more press releases Close

Redes sociais sobre Protagen

• Protagen na Wikipedia, Google News e Yahoo Finance
• Protagen na LinkedIn, X (Twitter) e YouTube